Background
==========

Mucinous cystic neoplasms (MCNs) represent one of the major cystic neoplasms of the pancreas. They have distinct clinicopathological features. They are seen in women in the fifth or sixth decades of life; only rarely are examples documented in men. The tumor is usually located in the tail of the pancreas. Macroscopically, the cysts are multilocular and they do not communicate with the pancreatic ductal system. Histologically, the lining epithelium consists of tall, columnar cells with abundant apical mucin, although cuboidal cells that lack obvious mucin may also be present. The epithelium may be bland in appearance or might range from mild to severe atypia resembling ovarian counterparts and include mucinous cystadenomas, borderline mucinous cystic tumors, and mucinous cystadenocarcinomas. Another distinct histologic feature is the presence of subepithelial hypercellular, ovarian-like spindle cell stroma, and its presence has become a requirement for the diagnosis of this entity \[[@B1],[@B2]\]. Here we report a case of mucinous cystic neoplasm of the pancreas with sarcomatous stroma metastasized to liver.

Case presentation
-----------------

A 46-year-old man presented with persistent epigastric and right upper quadrant pain. Endoscopic ultrasound studies revealed multiple cysts in the pancreas (Figures [1](#F1){ref-type="fig"}A,B). Computed tomography (Figure [1](#F1){ref-type="fig"}C) of the abdomen showed a large mass in the neck and body of the pancreas measuring 6.8 × 5.7 cm in cross-section, consistent with a cystic mass with internal hemorrhage. In addition, a 1.2 cm cystic mass in the pancreatic body and three adjacent cystic masses in the pancreatic tail measuring 2.3, 1.7, and 1.4 cm were identified. No pancreatic ductal dilatation was seen.

![**Endoscopic ultrasonography and computed tomography.A-B**) Endoscopic ulrasonography showing cysts in neck, body and tail of Pancreas. **C**) Computed tomography of pancreas showing cystic mass with hemorrhage.](1477-7819-11-100-1){#F1}

Pathologic findings
-------------------

A partial pancreatectomy removed four cysts ranging in size from 1.5 × 1.5 × 0.8 cm to 7.0 × 5.0 × 3.5 cm, located in the neck, body, and tail of the pancreas. All the cysts had a green-tan to red, smooth, glistening lining. The parenchyma separating the cysts was tan-yellow and focally indurated (Figure [2](#F2){ref-type="fig"}A).

![**Pictures of pancreatic cysts, cyst lined by benign mucinous epithelium, sarcomatous stroma in pancreas, and sarcomatoid metastatic foci in liver.** (**A**) Gross picture of pancreatic cysts occupying neck, body and tail. (**B**) Cyst lined by benign mucinous epithelium with underlying ovarian-like, storiform stroma (H & E, 10×) (**C**) Sarcomatous stroma in pancreas. Spindle stromal cells with fascicular growth pattern and nuclear palisading. Focal areas of dense, acellular, hyalinized tissue are evident (H & E, 20×) (**D**) Sarcomatoid metastatic foci in liver. Morphology is identical to lesion in pancreas (H & E, 20×).](1477-7819-11-100-2){#F2}

Histologically, the cysts were lined with columnar cells with mucinous laden cytoplasm and basally located, bland nucleus. Beneath the epithelial lining, a hypercellular ovarian-like stroma composed of spindle-shaped cells in a storiform growth pattern was observed (Figure [2](#F2){ref-type="fig"}B). In some areas, the spindle cells had a fascicular growth pattern and focally nuclear palisading was evident. In these areas, the cells had mild atypia; however, no increase in mitotic figures was detected. The focal areas of the stroma were composed of dense, acellular, hyalinized tissue (Figure [2](#F2){ref-type="fig"}C). A liver segment resected at the same time revealed a metastatic stromal lesion composed entirely of spindle-shaped cells identical to those seen in the pancreas but without the glandular component (Figure [2](#F2){ref-type="fig"}D). The uninvolved pancreas showed fibrosis and atrophy. All of the 11 lymph nodes were free of metastasis.

Immunohistochemistry
--------------------

The epithelial component of the cysts was positive for CAM 5.2 antibody (Figure [3](#F3){ref-type="fig"}A). The stromal component in both pancreas and liver was strongly positive for vimentin (Figure [3](#F3){ref-type="fig"}B) and weakly positive for inhibin (Figure [3](#F3){ref-type="fig"}C). However, the spindle cells were negative for CD34, estrogen receptor, progesterone receptor, androgen, calretinin, S-100, CD117, melan A, chromogranin, and synaptophysin. The Ki67 index of stroma was low, 1% to 3% (Figure [3](#F3){ref-type="fig"}D).

![**Immunohistochemical studies.** (**A**) Epithelial component of the lesion is CAM5.2 positive. Sarcomatous stroma shows strong vimentin (**B**) and weak inhibin (**C**) immunoreactivity. (**D**) Sarcomatous component has a low Ki67 index (1% to 3%).](1477-7819-11-100-3){#F3}

Discussion
==========

Sarcomatous neoplastic lesions arising from the stroma of MCNs of the pancreas have been described in the literature (Table [1](#T1){ref-type="table"}). The stromal component may be composed of bland, spindle cells with mild atypia and a small number of mitotic figures. These types of lesion have been described as 'mucinous cyst adenoma with mesenchymal overgrowth or mural nodules' \[[@B3],[@B4]\]. In these tumors, the sarcoma-like foci are benign and do not affect the prognosis adversely. Other reported examples of MCNs include an associated malignant spindle cell stroma with characteristic features of malignant fibrous histiosarcoma \[[@B5],[@B6]\], leiomyosarcoma \[[@B7]\], and undifferentiated pleomorphic high-grade sarcoma \[[@B8]-[@B10]\]. In some of these cases, the epithelial component was also malignant, so a diagnosis of carcinosarcoma was made.

###### 

Summary of reported cases of mucinous cystic neoplasm of pancreas with sarcomatous component

  **Reference**                                  **Demographic features**   **Epithelial component**       **Sarcomatous component**                                                                    
  ---------------------------------------------- -------------------------- ------------------------------ ------------------------------ ------------------------------------------------------------- ------------------------------------
  \[[@B8]\]                                      48                         M                              MCN, carcinosarcoma            Pleomorphism, high-grade atypia, atypical mitosis, necrosis   Vimentin (+)
  ER, PR (−)                                                                                                                                                                                            
  Liver and lymph node metastasis of carcinoma   S100 (−)                                                                                                                                               
  CD34 (−)                                                                                                                                                                                              
  SMA (−)                                                                                                                                                                                               
  \[[@B9]\]                                      70                         F                              MCN, invasive adenocarcinoma   Spindle cell sarcoma                                          Vimentin (+)
  Mucin 1 (+)                                                                                                                                                                                           
  \[[@B10]\]                                     67                         F                              MCN, invasive adenocarcinoma   Pleomorphic sarcoma                                           Vimentin (+)
  Moderate to high-grade atypia                  S100 (−)                                                                                                                                               
  Atypical mitosis                               c-Kit (−)                                                                                                                                              
  Metastasis to liver                                                                                                                                                                                   
  \[[@B3]\]                                      30                         F                              MCN                            MCN with mesenchymal overgrowth                               ER, PR (+)
  Mild atypia, low number of mitoses                                                                                                                                                                    
  No metastasis                                                                                                                                                                                         
  \[[@B11]\]                                     48                         F                              MCN with atypia                MCN with sarcomatous stroma                                   Vimentin, MSA, SMA
  ER and PR (+)                                                                                                                                                                                         
  66                                             F                          MCN with atypia                MCN with sarcomatous stroma    Vimentin,                                                     
  Moderate to high-grade atypia                  MSA, SMA,                                                                                                                                              
  Numerous mitoses                               S100 (variable),                                                                                                                                       
  Distant metastasis                             ER and PR (+)                                                                                                                                          
  67                                             M                          MCN, invasive adenocarcinoma   MCN with sarcomatous stroma    Vimentin,                                                     
  MSA, SMA,                                                                                                                                                                                             
  Moderate to high-grade atypia                  S100 (+)                                                                                                                                               
  ER and PR (−)                                                                                                                                                                                         
  Numerous mitoses                                                                                                                                                                                      
  Omental metastasis                                                                                                                                                                                    
  \[[@B5]\]                                      43                         F                              MCN                            MFH                                                           Vimentin, lysozyme, α1 antitrypsin
  \[[@B4]\]                                      45                         F                              MCN                            Pseudosarcomatous, mural nodules                              CK, EMA, Vimentin

ER, estrogen receptor; MCN, mucinous cystic neoplasm; MFH, malignant fibrous histiocytoma; MSA, muscle-specific actin; PR, progesterone receptor; SMA, smooth muscle actin.

In three cases reported by Wenig *et al*. \[[@B11],[@B12]\], stromal cells showed moderate to high-grade atypia, pleomorphism and increased numbers of mitotic figures. The sarcomatous component was angioinvasive. Two patients had metastatic lesions composed of sarcomatous lesion only. The epithelial component of one of these lesions showed features of invasive adenocarcinoma.

Our case differs from the previously reported literature by distant metastasis of only the stromal component, despite its morphologically benign features with bland spindle cells showing mild atypia, a low number of mitotic counts and a low Ki67 index. Both the sarcomatous stroma in the pancreas and the metastatic foci in the liver were strongly positive for vimentin and variably positive for inhibin. Estrogen receptor and progesterone receptor expression was not detected; this is not unlikely in MCN of pancreas arising in men.

Conclusion
==========

To the best of our knowledge, this is the first clinically MCN of the pancreas reported with distant metastasis of sarcomatous stromal component despite the relatively benign histologic features of the lesion. Although both epithelial and stromal components of the lesion are morphologically benign, the presence of a metastatic stromal focus in the liver renews the discussion that all pancreatic MCNs should be regarded as potentially malignant and that histology alone is not a definitive prospective indicator of behaviour \[[@B11],[@B13]\]. According to most of the reported literature, the MCN with sarcomatous tumor behaves more aggressively; therefore, it is most likely that the sarcomatous component appears to be responsible for the malignant behaviour of these tumors and supersedes the epithelial component in terms of defining the aggressiveness of these tumors.
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